| Vol. 7.27 – 8 August, 2022 |
| |
|
|
| Investigators clarified the pathophysiological significance of lysine crotonylation in cardiac injury and explored the underlying mechanism. [Circulation Research] |
| |
|
|
PUBLICATIONSRanked by the impact factor of the journal |
| |
|
|
| Scientists established a full set of methodologies for the efficient isolation and prolonged maintenance of functional primary adult human cardiomyocytes in vitro. [Signal Transduction and Targeted Therapy] |
|
|
|
| Researchers demonstrated that CDK7/12/13 were critical regulators of transcription activation in the heart that could be pharmacologically inhibited to improve heart failure with reduced ejection fraction. [Nature Communications] |
|
|
|
| Scientists explored the direct impact of T1AM on cardiomyocytes with a focus on the regulation of the intracellular temperature and natriuretic peptide expression. [Scientific Reports] |
| |
|
|
| Investigators showed that the upstream MAP3K ZAKβ was activated by cellular compression induced by osmotic shock and cyclic compression in vitro, and muscle contraction in vivo. [EMBO Journal] |
|
|
|
| The balance among quiescence, differentiation, and self-renewal of skeletal muscle stem cells (MuSCs) was tightly regulated by their intrinsic and extrinsic properties from the niche. Researchers investigated how the niche controls MuSC fate. [NPJ Regenerative Medicine] |
|
|
|
| To examine whether R-spondin (Rspo3) induced type I fibres, primary myoblasts prepared from mouse soleus muscles were exposed to a differentiation medium containing the mouse recombinant Rspo3 protein. [Scientific Reports] |
|
|
|
| The authors investigated the potential role of the tumor necrosis factor-like weak inducer of apoptosis (TWEAK)/Fn14 pathway in spinal muscular atrophy muscle pathology. [Skeletal Muscle] |
| |
|
|
| Investigators demonstrated that senescent vascular smooth muscle cells secrete increased number of extracellular vesicles. [GeroScience] |
|
|
|
| Researchers identified four splicing factors (MBNL1, RBPMS, RBPMS2, and RBFOX2) that correlated with myocardin across human smooth muscle cell tissues. [Cellular and Molecular Life Sciences] |
|
|
|
| The osteogenic differentiation of vascular smooth muscle cells (VSMCs) was the critical process for the development of arterial calcification, highly prevalent in patients with end-stage renal disease. Scientists eludicated the detailed mechanism of VSMCs calcification. [Cell Death & Disease] |
|
|
|
|
| The authors review recent advances in their understanding of regulatory mechanisms governing smooth muscle cell phenotypic modulation. [Vascular Pharmacology] |
|
|
|
| Scientists summarize muscle regeneration via P2Y1R and P2Y2R and speculated that P2Y1R and P2Y2R might be potential molecular triggers for muscle stem cells’ activation and proliferation via the p-ERK1/2 and phospholipase C pathways. [Purinergic Signalling] |
|
|
|
|
| Entrada Therapeutics, Inc. announced a new collaboration with the Myotonic Dystrophy Clinical Research Network supporting Establishing Biomarkers and Clinical Endpoints in Myotonic Dystrophy Type 1. [Entrada Therapeutics, Inc.] |
|
|
|
| In the biggest research grant ever from the research charity, the British Heart Foundation announced an award of £30 million over five years to an international team to develop gene-editing treatments for deadly heart conditions. [ScienceInsider] |
|
|
|
|
| September 12 – 14, 2022 Liverpool, England, United Kingdom |
| |
|
|
|
| Nationwide Children’s Hospital – Columbus, Ohio, United States |
|
|
|
| Gilead Sciences, Inc. – Foster City, California, United States |
|
|
|
| Ohio State University Wexner Medical Center – Columbus, Ohio, United States |
|
|
|
| Cincinnati Children’s Hospital Medical Center – Cincinnati, Ohio, United States |
|
|
|
| Sarepta Therapeutics, Inc. – Columbus, Ohio, United States |
|
|
|
|